Related references
Note: Only part of the references are listed.Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response
Qiyuan Li et al.
BMC BIOINFORMATICS (2011)
A gene expression signature identifies two prognostic subgroups of basal breast cancer
Renaud Sabatier et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Use of Standard Markers and Incorporation of Molecular Markers Into Breast Cancer Therapy Consensus Recommendations From an International Expert Panel
Manfred Kaufmann et al.
CANCER (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Multifactorial Approach to Predicting Resistance to Anthracyclines
Christine Desmedt et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A clinically relevant gene signature in triple negative and basal-like breast cancer
Achim Rody et al.
BREAST CANCER RESEARCH (2011)
Data driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer
Thomas Karn et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
Torsten O. Nielsen et al.
CLINICAL CANCER RESEARCH (2010)
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Christophe Ginestier et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Molecular Anatomy of Breast Cancer Stroma and Its Prognostic Value in Estrogen Receptor-Positive and -Negative Cancers
Giampaolo Bianchini et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Targeting Breast Cancer Stem Cells
Suling Liu et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Breast cancer molecular profiling with single sample predictors: a retrospective analysis
Britta Weigelt et al.
LANCET ONCOLOGY (2010)
Tumor size and survival in breast cancer-a reappraisal
William D. Foulkes et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A fuzzy gene expression-based computational approach improves breast cancer prognostication
Benjamin Haibe-Kains et al.
GENOME BIOLOGY (2010)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat et al.
BREAST CANCER RESEARCH (2010)
A compact VEGF signature associated with distant metastases and poor outcomes
Zhiyuan Hu et al.
BMC MEDICINE (2009)
Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
Bryan T. Hennessy et al.
CANCER RESEARCH (2009)
Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
Emad A. Rakha et al.
CLINICAL CANCER RESEARCH (2009)
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
Pierre Farmer et al.
NATURE MEDICINE (2009)
MOLECULAR ORIGINS OF CANCER Gene-Expression Signatures in Breast Cancer
Christos Sotiriou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
Achim Rody et al.
BREAST CANCER RESEARCH (2009)
The humoral immune system has a key prognostic impact in node-negative breast cancer
Marcus Schmidt et al.
CANCER RESEARCH (2008)
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2008)
The Interleukin-8 Pathway in Cancer
David J. J. Waugh et al.
CLINICAL CANCER RESEARCH (2008)
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak et al.
NATURE MEDICINE (2008)
Correction of technical bias in clinical microarray data improves concordance with known biological information
Aron C. Eklund et al.
GENOME BIOLOGY (2008)
CXC chemokines located in the 4q21 region are up-regulated in breast cancer
Ivan Bieche et al.
ENDOCRINE-RELATED CANCER (2007)
The erbB2+cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trial
A. Rody et al.
BREAST (2007)
Vascular endothelial growth factor and its relationship to inflammatory mediators
Laura S. Angelo et al.
CLINICAL CANCER RESEARCH (2007)
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression pro-filing study
Yun Gong et al.
LANCET ONCOLOGY (2007)
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
Andrew E. Teschendorff et al.
GENOME BIOLOGY (2007)
Prognostic markers in triple-negative breast cancer
Emad A. Rakha et al.
CANCER (2007)
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer
Kenneth R. Hess et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen
A. S. Doane et al.
ONCOGENE (2006)
The molecular portraits of breast tumors are conserved across microarray platforms
Zhiyuan Hu et al.
BMC GENOMICS (2006)
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Identification of molecular apocrine breast tumours by microarray analysis
P Farmer et al.
ONCOGENE (2005)
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Y Pawitan et al.
BREAST CANCER RESEARCH (2005)
affy -: analysis of Affymetrix GeneChip data at the probe level
L Gautier et al.
BIOINFORMATICS (2004)
Gene expression signature of fibroblast serum response predicts human cancer progression: Similarities between tumors and wounds
HY Chang et al.
PLOS BIOLOGY (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
JC Chang et al.
LANCET (2003)
Gene expression predictors of breast cancer outcomes
E Huang et al.
LANCET (2003)
Individuality and variation in gene expression patterns in human blood
AR Whitney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Identification of high risk breast-cancer patients by gene expression profiling
A Ahr et al.
LANCET (2002)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)